Cleared Traditional

K040227 - QLAB QUANTIFICATION SOFTWARE

K040227 is an FDA 510(k) clearance for QLAB QUANTIFICATION SOFTWARE, manufactured by Philips Ultrasound. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 15-day FDA review.

K040227 · Philips Ultrasound · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2004
Decision
15d
Days
Class 2
Risk

K040227 is an FDA 510(k) clearance for the QLAB QUANTIFICATION SOFTWARE. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Philips Ultrasound (Andover, US). The FDA issued a Cleared decision on February 17, 2004 after a review of 15 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Philips Ultrasound devices

FDA 510(k) Submission Details - K040227

510(k) Number K040227 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 02, 2004
Decision Date February 17, 2004
Days to Decision 15 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
92d faster than avg
Panel avg: 107d · This submission: 15d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1193
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K040227.
VITREA2 VERSION 3.5
K040305 · Vital Images, Inc. · Feb 2004
COLOR LCD DISPLAY, MODEL RADIFORCE R22
K033466 · Eizo Nanao Corporation · Feb 2004
INTEGRIS 3D-RA, RELEASE 4.2
K040254 · Philips Medical Systems North America Co. · Feb 2004
ENSPHERE TEMPO JETSTREAM WORKSPACE CARDIOLOGY MODULE
K040142 · Adac Laboratories · Feb 2004
CHASE CARDIAC ANALYSIS SYSTEM
K032531 · Chase Medical, Inc. · Feb 2004
SIENET COSMOS
K033831 · Siemens AG Medical Solutions · Dec 2003